Literature DB >> 7621895

Distribution of beta 3-adrenoceptor mRNA in human tissues.

D E Berkowitz1, N A Nardone, R M Smiley, D T Price, D K Kreutter, R T Fremeau, D A Schwinn.   

Abstract

The beta 3-adrenoceptor is a G protein-coupled receptor which mediates metabolic functions of the endogenous catecholamines epinephrine and norepinephrine. Questions exist regarding distribution of the beta 3-adrenoceptor in human tissue. In order to examine the distribution of beta 3-adrenoceptor mRNA in human tissues, we used sensitive and specific RNase protection assays without previous PCR amplification in an extensive list of human tissues. We confirm the presence of beta 3-adrenoceptor mRNA in human white fat from several locations, gall bladder, and small intestine, as well as extend the distribution of beta 3-adrenoceptor mRNA to previously uncharacterized human tissues such as stomach and prostate. The presence of beta 3-adrenoceptor mRNA in human white adipose tissue has important implications regarding possible use of beta 3-adrenoceptor selective agonists as anti-obesity agents, and the demonstration of beta 3-adrenoceptor mRNA in a number of gastrointestinal tissues and prostate raises the question of the role of the beta 3-adrenoceptor in motility and secretory processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621895     DOI: 10.1016/0922-4106(95)90098-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

Review 1.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

2.  Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.

Authors:  Fangfang Jin; Chunhua Lu; Xianqiang Sun; Weihua Li; Guixia Liu; Yun Tang
Journal:  Mol Divers       Date:  2011-03-20       Impact factor: 2.943

Review 3.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

4.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

Review 5.  Tools to study beta3-adrenoceptors.

Authors:  Wim Vrydag; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-09       Impact factor: 3.000

6.  CL 316,243, a selective beta3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle.

Authors:  Luiz Carlos C Navegantes; Neusa M Z Resano; Amanda Martins Baviera; Renato H Migliorini; Isis C Kettelhut
Journal:  Pflugers Arch       Date:  2005-08-10       Impact factor: 3.657

7.  Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.

Authors:  Valentina Vasina; Ferdinando Giannone; Marco Domenicali; Rocco Latorre; Annalisa Berzigotti; Paolo Caraceni; Marco Zoli; Fabrizio De Ponti; Mauro Bernardi
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

8.  Expression of beta 3-adrenoceptor mRNA in rat brain.

Authors:  R J Summers; M Papaioannou; S Harris; B A Evans
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

9.  Tissue functions mediated by beta(3)-adrenoceptors-findings and challenges.

Authors:  Martin C Michel; Peter Ochodnicky; Roger J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-03       Impact factor: 3.000

10.  Beta 2-adrenergic receptor regulation of human neutrophil function is sexually dimorphic.

Authors:  Catherine de Coupade; Robert W Gear; Paul F Dazin; Herve Y Sroussi; Paul G Green; Jon D Levine
Journal:  Br J Pharmacol       Date:  2004-10-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.